The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureBertram Pitt, Janet Wittes, Faı̈ez Zannad et al.|Survey of Anesthesiology|2000Cited by 2.9k
Celecoxib for the Prevention of Sporadic Colorectal AdenomasMonica M. Bertagnolli, Ernest T. Hawk, Craig Eagle et al.|New England Journal of Medicine|2006Cited by 1k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney DiseaseDick de Zeeuw, Glenn M. Chertow, Hans‐Henrik Parving et al.|New England Journal of Medicine|2013Cited by 990
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS InhibitorsMatthew R. Weir, Bertram Pitt, George L. Bakris et al.|New England Journal of Medicine|2014Cited by 658
Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyPaul Harmatz, Stuart J. Swiedler, Roberto Giugliani et al.|The Journal of Pediatrics|2006Cited by 364